Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

Impax Labs. Introduces Oxymorphone Hydrochloride Extended-Release Tablets

RELATED NEWS
Trade IPXL now with 
1/4/2013 8:17 AM ET

Impax Laboratories Inc.(IPXL: Quote) said it is commencing shipment of Oxymorphone Hydrochloride Extended-Release Tablets, via. Global Pharmaceuticals, Impax's generics unit.

In June 2010, Impax inked a deal with Endo Pharmaceuticals and Penwest Pharmaceuticals to settle U.S. patent litigation concerning the production and sale of its Oxymorphone Hydrochloride Extended-Release Tablets approved by the U.S. Food and Drug Administration as therapeutically equivalent to the original formulation of OPANA ER. According to the settlement, Endo agreed to grant Impax a license to sell Impax's approved product on January 1, 2013.

Impax also noted that it is actively participating in efforts to support prescriber and patient education of this product through the FDA-approved Risk Evaluation and Mitigation Strategy. Oxymorphone Hydrochloride Extended-Release Tablets are indicated for the relief of moderate to severe pain in patients requiring continuous, around-the-clock opioid treatment for an extended period of time.

Click here to receive FREE breaking news email alerts for Impax Laboratories Inc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Starting this month, NASA will send a remotely piloted research aircraft as high as 65,000 feet over the tropical Pacific Ocean to probe unexplored regions of the upper atmosphere for answers to how a warming climate is changing Earth. The first flights of the Airborne Tropical Tropopause Experiment (ATTREX), a multi-year airborne science campaign with a heavily instrumented Global Hawk aircra China's exports advanced more than expected in December, boosting hopes of a rebound in growth for the world's second largest economy. Overseas shipments surged 14.1 percent year-on-year in December, the fastest pace in seven months, data released by the General Administration of Customs showed Thursday. The outcome was much stronger than the 5 percent increase forecast by economists. After ending the two previous sessions in the red, stocks moved back to the upside during trading on Wednesday. The markets benefited from optimism about the outlook for corporate earnings following the release of quarterly results from Alcoa (AA). The major averages ended the day firmly in positive territory but well off their best levels of the day.
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.